These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recurrence rates after the first course of isotretinoin. White GM; Chen W; Yao J; Wolde-Tsadik G Arch Dermatol; 1998 Mar; 134(3):376-8. PubMed ID: 9521042 [No Abstract] [Full Text] [Related]
24. Acne: what's new? Cargnello JA Med J Aust; 1996 Aug; 165(3):153-8. PubMed ID: 8709882 [No Abstract] [Full Text] [Related]
25. Management of adult acne and acne variants. Cunliffe WJ J Cutan Med Surg; 1998 May; 2 Suppl 3():7-13. PubMed ID: 9873117 [No Abstract] [Full Text] [Related]
27. [Infantile acne and isotretinoin]. Léauté-Labrèze C; Gautier C; Labbé L; Taieb A Ann Dermatol Venereol; 1998 Feb; 125(2):132-4. PubMed ID: 9747233 [TBL] [Abstract][Full Text] [Related]
28. Isotretinoin for acne vulgaris. al-Khawajah MM Int J Dermatol; 1996 Mar; 35(3):212-5. PubMed ID: 8655243 [TBL] [Abstract][Full Text] [Related]
29. Postinflammatory hyperpigmentation in an Asian patient: a dramatic response to oral isotretinoin (13-cis-retinoic acid). Winhoven SM; Ahmed I; Owen CM; Lear JT Br J Dermatol; 2005 Feb; 152(2):368-9. PubMed ID: 15727656 [No Abstract] [Full Text] [Related]
30. Adding isotretinoin to lithium carbonate probably caused mild lithium toxicity. Lambe J Aust N Z J Psychiatry; 2014 Nov; 48(11):1066. PubMed ID: 24874246 [No Abstract] [Full Text] [Related]
31. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243 [TBL] [Abstract][Full Text] [Related]
32. [Systemic treatment of acne with isotretinoin: current status]. Plewig G; Albrecht G; Henz BM; Meigel W; Schöpf E; Stadler R Hautarzt; 1997 Dec; 48(12):881-5. PubMed ID: 9486358 [TBL] [Abstract][Full Text] [Related]
33. Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol. Lestringant GG; Frossard PM; Agarwal M; Galadari IH Int J Dermatol; 1997 Nov; 36(11):859-62. PubMed ID: 9427082 [TBL] [Abstract][Full Text] [Related]
34. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Seukeran DC; Cunliffe WJ Br J Dermatol; 1998 Jul; 139(1):99-101. PubMed ID: 9764156 [TBL] [Abstract][Full Text] [Related]
35. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Libow LF; Friar DA Cutis; 1999 Aug; 64(2):87-90. PubMed ID: 10467498 [TBL] [Abstract][Full Text] [Related]
37. Treatment of acne. O'Loughlin S Ir Med J; 1995; 88(4):114-5. PubMed ID: 7672941 [No Abstract] [Full Text] [Related]
38. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. Ioannides D; Rigopoulos D; Katsambas A Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595 [TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of isotretinoin in the treatment of acne. Part 2. A chronic medication plan profiling study. Wessels F; Anderson AN; Kropman K S Afr Med J; 1999 Jul; 89(7 Pt 2):785-90. PubMed ID: 10470318 [TBL] [Abstract][Full Text] [Related]
40. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Zane LT; Leyden WA; Marqueling AL; Manos MM Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]